Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs
From MaRDI portal
Cited in
(21)- Control of type I error rates in Bayesian sequential designs
- Construction of an Optimal Sequential Plan for Testing a Treatment for an Adverse Effect
- Principles of Optimal Sequential Planning
- Bayesian designs and the control of frequentist characteristics: a practical solution
- BAYES DISCRETE SEQUENTIAL BOUNDARIES FOR CLINICAL TRIALS
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes
- An Approximation Approach for Response-Adaptive Clinical Trial Design
- Bayesian uncertainty directed trial designs
- Nonparametric Sequential Bayes Estimation of the Distribution Function
- A Review of Modern Computational Algorithms for Bayesian Optimal Design
- Bayesian group sequential designs for cluster-randomized trials
- Optimal adaptive allocation using deep reinforcement learning in a dose-response study
- The performance of fixed-horizon, look-ahead procedures compared to backward induction in Bayesian adaptive-randomization decision-theoretic clinical trial design
- Stopping rules for phase II clinical trials: an overview
- A Bayesian approach to sequential meta-analysis
- Bayesian sequential meta-analysis design in evaluating cardiovascular risk in a new antidiabetic drug development program
- Response-adaptive decision-theoretic trial design: operating characteristics and ethics
- Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin
- A Bayesian decision-theoretic sequential response-adaptive randomization design
- Sequential monitoring of response-adaptive randomized clinical trials
- Simulation-based sequential Bayesian design
This page was built for publication: Group Sequential Clinical Trials: A Classical Evaluation of Bayesian Decision-Theoretic Designs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4323583)
